CLYM EPS Estimates
Climb Bio, Inc.
$10.83
+$0.54(+5.25%)
41
Overall
60
Value
27
Tech
36
Quality
Market Cap
$591.02M
Volume
100.35K
52W Range
$1.64 - $18.33
Target Price
$27.86
CLYM EPS estimates: the consensus estimate for Climb Bio, Inc.'s current fiscal year is -$0.78 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CLYM EPS Estimates
- EPS estimate, current quarter
- $-0.19
- EPS estimate, next quarter
- $-0.20
- EPS estimate, current year
- $-0.78
- EPS estimate, next year
- $-1.02
- EPS growth, 3-year
- +20.02%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.88 |
| 2024 | $-1.53 |
| 2023 | $-1.30 |
| 2022 | $-1.72 |
| 2021 | $-4.24 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLYM | $10.83 | +5.2% | 100.35K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |